J.Henderson Gl.Life Sciences F.H1
IE00BRJG6Y37
J.Henderson Gl.Life Sciences F.H1/ IE00BRJG6Y37 /
| NAV18/06/2024 |
Chg.-0.0500 |
Type of yield |
Investment Focus |
Investment company |
| 26.1300USD |
-0.19% |
paying dividend |
Equity
Worldwide
|
Janus Henderson Inv. ▶ |
Investment goal
The Fund seeks long - term growth of capital by investing primarily in life - science equity securities of companies located anywhere in the world and selected for their growth potential.
Master data
| Type of yield: |
paying dividend |
| Funds Category: |
Equity |
| Region: |
Worldwide |
| Branch: |
Sector Health / Pharma |
| Benchmark: |
MSCI World Healthcare Index |
| Business year start: |
01/01 |
| Last Distribution: |
15/04/2024 |
| Depository bank: |
J.P. Morgan SE, Dublin Branch |
| Fund domicile: |
Ireland |
| Distribution permission: |
Austria, Germany, Switzerland |
| Fund manager: |
Andy Acker, Daniel Lyons |
| Fund volume: |
3.92 bill.
USD
|
| Launch date: |
20/10/2014 |
| Investment focus: |
- |
Conditions
| Issue surcharge: |
0.00% |
| Max. Administration Fee: |
0.80% |
| Minimum investment: |
2,500.00 USD |
| Deposit fees: |
- |
| Redemption charge: |
0.00% |
| Key Investor Information: |
Download (Print version) |
Investment company
| Funds company: |
Janus Henderson Inv. |
| Address: |
201 Bishopsgate, EC2M 3AE, London |
| Country: |
United Kingdom |
| Internet: |
www.janushenderson.com/
|
Assets
| Stocks |
|
99.47% |
| Bonds |
|
0.29% |
| Cash |
|
0.24% |
Countries
| United States of America |
|
73.24% |
| Denmark |
|
7.12% |
| United Kingdom |
|
4.21% |
| Switzerland |
|
3.34% |
| France |
|
2.50% |
| Ireland |
|
2.21% |
| Netherlands |
|
1.73% |
| Japan |
|
1.39% |
| Virgin Islands (British) |
|
0.77% |
| China |
|
0.72% |
| Cayman Islands |
|
0.24% |
| Cash |
|
0.24% |
| Canada |
|
0.18% |
| Others |
|
2.11% |
Branches
| Pharma/Biotechnology |
|
62.84% |
| Healthcare services |
|
16.78% |
| Healthcare appliances |
|
16.12% |
| Parma, wholesale |
|
1.52% |
| Cash |
|
0.24% |
| Others |
|
2.50% |
